Sensen Xu
Zhengzhou, 450003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Brief discussion on pathological diagnosis of vascular malformation-associated syndromes
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: September 07, 2026
Predicting recurrent glioblastoma clinical outcome to immune checkpoint inhibition and low-dose bevacizumab with tumor in situ fluid circulating tumor DNA analysis.
Journal: Cancer immunology, immunotherapy : CII
Published: May 08, 2024
Diffuse fibroadipose vascular anomaly of lower limb: report of a case
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: April 01, 2024
Dynamic Monitoring of Circulating Tumor DNA to Predict the Risk of Non In Situ Recurrence of Postoperative Glioma: A Prospective Cohort Study.
Journal: Cancer medicine
Published: March 16, 2024
Well-differentiated/dedifferentiated liposarcoma associated with myxoid-like morphology: a clinicopathological and molecular genetic characteristics analysis of 34 cases
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: January 28, 2024
Tracking tumor evolution during the first-line treatment in brain glioma via serial profiling of cell-free tumor DNA from tumor in situ fluid.
Journal: Frontiers in oncology
Published: June 12, 2023
Clinicopathological characteristics of 16 cases of intramuscular hemangioma capillary type
Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology
Published: March 27, 2023
Genomic alterations of oligodendrogliomas at distant recurrence.
Journal: Cancer medicine
Published: January 18, 2023
Molecular and clonal evolution in vivo reveal a common pathway of distant relapse gliomas.
Journal: iScience
Published: October 06, 2022
Real-time longitudinal analysis of human gliomas reveals in vivo genome evolution and therapeutic impact under standardized treatment.
Journal: Clinical and translational medicine
Published: April 02, 2022
Tumor DNA From Tumor In Situ Fluid Reveals Mutation Landscape of Minimal Residual Disease After Glioma Surgery and Risk of Early Recurrence.
Journal: Frontiers in oncology
Published: July 15, 2021
Integrating real-time in vivo tumour genomes for longitudinal analysis and management of glioma recurrence.
Journal: Clinical and translational medicine
Published: June 21, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026